AbbVie Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant bullish stance on AbbVie (NYSE:ABBV) has been observed through unusual options activity. The sentiment among these big-money traders is split between 60% bullish and 40% bearish. The whales have been targeting a price range from $100.0 to $165.0 for AbbVie over the last 3 months. Morgan Stanley maintains an Overweight rating on AbbVie with a price target of $193, while Raymond James downgraded its action to Outperform with a price target of $177.
October 19, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Unusual options activity indicates a significant bullish stance on AbbVie. The sentiment among big-money traders is 60% bullish and 40% bearish. Analysts from Morgan Stanley and Raymond James have set price targets at $193 and $177 respectively.
The unusual options activity, with a significant bullish stance, indicates that there is a high expectation of AbbVie's stock price increasing. This is further supported by the price targets set by Morgan Stanley and Raymond James, which are both higher than the current stock price. Therefore, it is likely that the stock price will go up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100